Friday, December 13, 2019, 10:00am-1:15pm
A Special Lecture Presented by:
County of Los Angeles Department of Public Health, Substance Abuse Prevention and Control Program
UCLA Integrated Substance Abuse Programs and the Pacific Southwest Addiction Technology Transfer Center
Beth A. Rutkowski, MPH, Director of Training & Epidemiologist, UCLA Integrated Substance Abuse Programs, Co-Director Pacific Southwest Addiction Technology Transfer Center (HHS Region 9)
David Hindman, PhD, Chief, Clinical Standards and Training Unit Substance Abuse Prevention & Control
This Lecture Series presentation will provide a detailed review of local and national emerging drug trends. Epidemiological data on synthetic drugs, fentanyl, other synthetic opioids, marijuana, methamphetamine, cocaine, mixed opioids/stimulants and vaping (marijuana and nicotine) will be presented. The presentation will define key terms, describe the major classes of emerging drugs, present available data on the extent of use, and discuss the acute and chronic effects.
At the end of this presentation, participants will be able to: 1) Describe the current information on the availability and patterns of emerging drug tends in the United States. 2) Identify the key characteristics and acute and chronic effects of synthetic drugs, most notably synthetic opioids (fentanyl), synthetic cannabinoids (spice) and synthetic cathinones (bath salts). 3) Identify the key characteristics and acute and chronic effects of mixed opioids and stimulants. 4) Explain strategies for communicating the dangers involved with the use of emerging drugs, including the current vaping lung illness epidemic.
The Alhambra Auditorium
1000 South Fremont Avenue, Alhambra, CA 91803
Friday, December 13, 2019
10:00am - 1:15pm
Register online at https://tinyurl.com/SAPC12-13
Scientists Larissa Mooney and Yih-Ing Hser from the UCLA Integrated Substance Abuse Programs (ISAP) will lead a $25 million study funded by the National Institutes of Health to test treatments for opioid addiction in rural America.
A separate grant of $3.3 million from the NIH was awarded to another UCLA ISAP researcher, Suzette Glasner-Edwards, who will study the effectiveness of using text messages to help people with opioid addiction adhere to their treatment regimens.
A 5-part training developed in 2019 by the Pacific Southwest Addiction Technology Transfer Center.
2019 Multinational Cannabis Public Health Summit Proceedings and Calls to Action Released. Upcoming Cannabis Public Health Network Announced.
The Cannabis Use Disorder and Affective Management Training Study is seeking individuals between the ages of 18-25 who have problems with cannabis use, experience anxiety or depression, and have trouble managing those feelings of anxiety and depression.
UCLA ISAP has collaborated with the Substance Abuse and Mental Health Services Administration (SAMHSA) and the SAMHSA Grantee Data Technical Assistance (GDTA) team to publish Staying in Touch: A Fieldwork Manual of Tracking Procedures (Third Edition).
Staying in Touch is designed to assist SAMHSA-funded grantees to stay in touch with people receiving services and to meet GPRAMA reporting requirements. The manual includes information on numerous staying-in-touch, tracking, and locating procedures from the simple and inexpensive to the complex and costly.